With the analysis among 118 patents, we discovered top 37 key players by total patent application. Principia Biopharma, Inc., Alnylam Pharmaceuticals, Inc., Peptimmune, Inc. are dominant in this area. They take 34.75% of the total patent filing.
California, United States
Patent: 15
Massachusetts, United States
Patent: 14
Massachusetts, United States
Patent: 12
New York, United States
Patent: 11
Tokyo-to, Japan
Patent: 10
Hamburg, Germany
Patent: 5
No data, please try another search term
With the analysis among related 30 patents applied in the last 5 years. We discover 13 most active companies in this area. The fast-growing Alnylam Pharmaceuticals, Inc., Topas Therapeutics GmbH, Principia Biopharma, Inc. take 63.33% of patent filing during this period.
Massachusetts, United States
Patent: 14
Hamburg, Germany
Patent: 3
California, United States
Patent: 2
New York, United States
Patent: 1
undefined undefined
Patent: 1
Guangdong Sheng, China
Patent: 1
With the analysis among related 30 patents in last 5 years, we discover 10 new entrants. Alnylam Pharmaceuticals, Inc., MorphoSys AG, Skin Diseases Hospital, China Academy of Medical Science are the most active new entrants in this area.
Massachusetts, United States
Patent: 14
undefined undefined
Patent: 1
Guangdong Sheng, China
Patent: 1
Delaware, United States
Patent: 1
undefined undefined
Patent: 1
With the analysis among 38 patents, we discovered top 7 universities and scientific research institutions by total patent application. President & Fellows of Harvard College, Keio University, New York University are dominant in this area. They take 65.79% of the total patent filing.
Massachusetts, United States
Patent: 12
New York, United States
Patent: 3
Illinois, United States
Patent: 1
Bern, Switzerland
Patent: 1